Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluating the Impact of a Clinical Breast Examination Screening Program Within the Irapen Project Publisher Pubmed



Rahimi F1 ; Tolouei S2 ; Ravankhah Z3 ; Mohammadisefiddashti F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Health Economics, School of Management and Medical Information Sciences, Isfahan University of Medical Science, Isfahan, Iran
  3. 3. Cancer Registry of Health Deputy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Asian Pacific Journal of Cancer Prevention Published:2024


Abstract

Purpose: Breast cancer is a prevalent global cancer and a leading cause of mortality in developed countries. In 2015, Iran introduced the Package of Essential Noncommunicable Diseases (IraPEN) as a pilot project to tackle prevalent noncommunicable diseases, including breast cancer. However, there is limited research evaluating the implementation, costs, and outcomes of breast cancer screening within IraPEN. Therefore, this study aims to investigate the costs and outcomes of the clinical breast examination screening program in Isfahan from 2017 to 2020. Method: This descriptive cost-outcome study utilized data from 450,876 individuals aged 30 to 69 who participated in clinical breast examination screening. The outcomes assessed in this program encompassed the number of participants, the number of individuals identified with symptoms, referrals to the next level of examination, the number of individuals undergoing mammography, recorded mammography results, and the number of cases of breast cancer identified. Direct costs were estimated, including personnel, infrastructure, equipment, and other related expenses. Results: The findings revealed that the direct costs of the breast cancer screening program in Isfahan between 2017 and 2020 were 310,514,608,558 Rials, equivalent to approximately 15,470,633 PPP$. These expenses led to the identification of 134,508 individuals with symptoms, referrals of 258,599 individuals to the subsequent level of examination, and approximately 55,974 individuals undergoing mammography tests. Conclusion: This study demonstrates that the breast cancer screening program provides a significant number of women in the target age group with breast self-examination education while raising public awareness about this disease. © (2024), (Asian Pacific Organization for Cancer Prevention). All rights reserved.
Other Related Docs
9. The Most Common Cancers in Iranian Women, Iranian Journal of Public Health (2009)
12. Barriers to Breast Self-Examination Among Iranian Women, Iranian Journal of Nursing and Midwifery Research (2019)
14. Incidence of Breast and Cervical Intraepithelial Lesions: Results of a Screening Program for Women, Journal of Obstetrics, Gynecology and Cancer Research (2022)
15. Results of the Program for Prevention and Control of Non-Communicable Diseases in Isfahan, Scientific Journal of Kurdistan University of Medical Sciences (2021)
37. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
38. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)
46. Epidemiology and Trend of Cancer in Isfahan 2005-2010, Journal of Research in Medical Sciences (2011)